BioLineRx (BLRX) Net Equity Issued and Repurchased (2015 - 2018)
BioLineRx's (BLRX) quarterly Net Equity Issued and Repurchased came in at $1.4 million in Q2 2018, down 94.57% year-on-year from $26.2 million in Q2 2017, and little changed quarter-over-quarter from $1.4 million in Q1 2018.
BioLineRx (BLRX) Net Equity Issued and Repurchased (2015 - 2018) Analysis & Trends
BioLineRx's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $1.4 million for Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 1.42 Mn |
| Jun 30, 2018 | 1.42 Mn |
| Mar 31, 2018 | 1.42 Mn |
| Mar 31, 2018 | 1.42 Mn |
| Jun 30, 2017 | 26.23 Mn |
| Jun 30, 2017 | 26.23 Mn |
| Mar 31, 2017 | 2.09 Mn |
| Mar 31, 2017 | 2.09 Mn |
| Mar 31, 2016 | 1.60 Mn |
| Mar 31, 2016 | 1.60 Mn |
| Sep 30, 2015 | 199,000.00 |
| Sep 30, 2015 | 199,000.00 |
| Jun 30, 2015 | 2.19 Mn |
| Jun 30, 2015 | 2.19 Mn |
| Mar 31, 2015 | 26.46 Mn |
| Mar 31, 2015 | 26.46 Mn |